Xironetic, founded in Oklahoma City, focuses on revolutionizing surgical planning through advanced technology. Their core mission is to enhance surgical precision and outcomes using Augmented Reality (AR) and Computer Vision. Xironetic's flagship product, IntraOpVSP, transforms traditional two-dimensional surgical planning into a three-dimensional extended reality, providing surgeons with a heads-up display during procedures. The company caters primarily to CranioMaxillofacial, Thoracic, and Abdominal surgeries, aiming to offer unparalleled control and accuracy in the operating room.
Notable affiliated individuals and investors include leading experts in medical technology and venture capital firms specializing in healthcare innovations. Xironetic has achieved significant milestones, including FDA clearance for IntraOpVSP, underscoring its commitment to safety and efficacy. The company's impact is evident in its ability to improve surgical outcomes and streamline complex procedures, positioning it as a pioneer in the integration of AR in medical practice.
